Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 3116Neoplasms 2459Carcinoma, Non-Small-Cell Lung 1858Prostatic Neoplasms 1623Colorectal Neoplasms 1401Lung Neoplasms 1293Multiple Myeloma 930Neoplasm Metastasis 919Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 853Ovarian Neoplasms 800Melanoma 782Carcinoma, Hepatocellular 733Stomach Neoplasms 647Squamous Cell Carcinoma of Head and Neck 635Recurrence 635Brain Neoplasms 624Head and Neck Neoplasms 598Glioblastoma 558Lymphoma 549Uterine Cervical Neoplasms 535Triple Negative Breast Neoplasms 511Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Carcinoma, Renal Cell 501Hematologic Neoplasms 464Urinary Bladder Neoplasms 460Endometrial Neoplasms 457Colonic Neoplasms 445Sarcoma 433Lymphoma, Non-Hodgkin 432

Interventions

Methods 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Ventricular Dysfunction, Left × 1 year × Clear all
NCT07572175 2026-05-07

SPARTACUS

Icahn School of Medicine at Mount Sinai

Phase 2 Not yet recruiting
60 enrolled
Lymphoid

Lymphoma, Ventricular Dysfunction, Left, Cardiotoxicity

NCT07515859 2026-04-13

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Yonsei University

Completed
31,486 enrolled

Heart Failure, Ventricular Dysfunction, Left, Cardiotoxicity

NCT04892667 2025-08-13

DETECT

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
128 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡